Open | $72.480 |
Close | $71.880 |
Volume / Avg. | 1.004M / 1.069M |
Day Range | 71.040 - 72.870 |
52 Wk Range | 51.790 - 89.910 |
Market Cap | $11.299B |
P/E Ratio | 52.180 |
Dividend Yield | 0.440% |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | % |
Days to Cover | 3.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Techne (NASDAQ: TECH) through any online brokerage.
Other companies in Bio-Techne’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Bio-Techne (NASDAQ: TECH) was reported by Stifel on Friday, February 2, 2024. The analyst firm set a price target for 65.00 expecting TECH to fall to within 12 months (a possible -9.57% downside). 15 analyst firms have reported ratings in the last year.
The stock price for Bio-Techne (NASDAQ: TECH) is $71.88 last updated March 18, 2024 at 4:16 PM EDT.
A quarterly cash dividend of $0.08 per share of Class A Common Stock. The quarterly cash dividend was payable on February 26, 2024 to stockholders of record on February 9, 2024.
Bio-Techne’s Q3 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Bio-Techne.
Bio-Techne is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.